These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Poison centers' experience with methylphenidate abuse in pre-teens and adolescents. Klein-Schwartz W; McGrath J J Am Acad Child Adolesc Psychiatry; 2003 Mar; 42(3):288-94. PubMed ID: 12595781 [TBL] [Abstract][Full Text] [Related]
29. Abuse, misuse, and suicidal substance use by children on school property. Vakkalanka JP; King JD; Holstege CP Clin Toxicol (Phila); 2015 Nov; 53(9):901-7. PubMed ID: 26503790 [TBL] [Abstract][Full Text] [Related]
30. Melatonin exposures reported to Texas poison centers in 1998-2003. Forrester MB Vet Hum Toxicol; 2004 Dec; 46(6):345-6. PubMed ID: 15587262 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of dabigatran exposures reported to poison control centers. Conway SE; Schaeffer SE; Harrison DL Ann Pharmacother; 2014 Mar; 48(3):354-60. PubMed ID: 24301686 [TBL] [Abstract][Full Text] [Related]
32. A retrospective review of isolated gliptin-exposure cases reported to a state poison control system. Darracq MA; Toy JM; Chen T; Mo C; Cantrell FL Clin Toxicol (Phila); 2014 Mar; 52(3):226-30. PubMed ID: 24580063 [TBL] [Abstract][Full Text] [Related]
33. Medical outcomes of bromethalin rodenticide exposures reported to US poison centers after federal restriction of anticoagulants. Feldman R; Stanton M; Borys D; Kostic M; Gummin D Clin Toxicol (Phila); 2019 Nov; 57(11):1109-1114. PubMed ID: 30892957 [No Abstract] [Full Text] [Related]
34. Increasing frequency and fatality of poison control center reported exposures involving medication and multiple substances: data from reports of the American Association of Poison Control Centers 1984-2013. Greenwald PW; Farmer BM; O'Neill M; Essner RA; Flomenbaum NE Clin Toxicol (Phila); 2016 Aug; 54(7):590-6. PubMed ID: 27214065 [TBL] [Abstract][Full Text] [Related]
35. Characteristics of hand sanitizer ingestions by adolescents reported to poison centers. Forrester MB Int J Adolesc Med Health; 2015 Feb; 27(1):69-72. PubMed ID: 24887952 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of centrally acting cholinesterase inhibitor exposures in adults. McCain KR; Sawyer TS; Spiller HA Ann Pharmacother; 2007 Oct; 41(10):1632-7. PubMed ID: 17848422 [TBL] [Abstract][Full Text] [Related]
37. Unintentional pediatric exposures to central alpha-2 agonists reported to the National Poison Data System. Wang GS; Le Lait MC; Heard K J Pediatr; 2014 Jan; 164(1):149-52. PubMed ID: 24094880 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of quetiapine abuse and misuse reported to poison centers. Klein-Schwartz W; Schwartz EK; Anderson BD J Addict Med; 2014; 8(3):195-8. PubMed ID: 24662370 [TBL] [Abstract][Full Text] [Related]
39. Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers. Ni A; Lee Cantrell F; Clark RF Am J Emerg Med; 2018 Aug; 36(8):1459-1462. PubMed ID: 29754964 [TBL] [Abstract][Full Text] [Related]